HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cell growth-inhibitory effects of derivatives of antitumor cyclic hexapeptide RA-V obtained from Rubiae radix (V).

Abstract
Alkylehter and ester derivatives of the antitumor cyclic hexapeptide RA-V obtained from the roots of Rubia cordifolia (Rubiaceae) were synthesized and bioassayed for activity against cultured tumor cells. RA-V and its n-hexylether showed significant effects against human nasopharynx carcinoma (KB), P388 lymphocytic leukemia and MM2 mammary carcinoma cells. The activity values (log 1/IC50) of ether derivatives of RA-V gave an upward parabolic or bilinear relationship when plotted against log P (P: partition coefficient determined with the 1-octanol/water system) as the carbon number of the side chain at the phenol moiety of RA-V was increased, the optimum log P values being in the range from 3.5 to 4.9. The ester derivatives showed a similar relationship, the optimum log P values being 6.3-6.7, which is higher than that of the ether derivatives. The lethal effect of RA-V on KB cells was clearly different from that of mitomycin C, and RA-V was concluded to be a "time-dependent drug" like vinblastine.
AuthorsH Itokawa, K Takeya, N Mori, M Takanashi, H Yamamoto, T Sonobe, S Kidokoro
JournalGan (Gan) Vol. 75 Issue 10 Pg. 929-36 (Oct 1984) ISSN: 0016-450X [Print] Japan
PMID6510638 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Peptides, Cyclic
  • RA V
  • RA VII
Topics
  • Animals
  • Antineoplastic Agents (chemical synthesis)
  • Cell Division (drug effects)
  • Cell Line
  • Cell Survival (drug effects)
  • Humans
  • Kinetics
  • Leukemia P388 (pathology)
  • Mammary Neoplasms, Experimental (pathology)
  • Mice
  • Mouth Neoplasms
  • Nasopharyngeal Neoplasms
  • Peptides, Cyclic (chemical synthesis, toxicity)
  • Plants, Medicinal
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: